Involvement of Sp1 in lipopolysaccharide-induced expression of HDC mRNA in RAW 264 cells

Noriyasu Hirasawa1, Masashi Torigoe, Kuniyuki Kano

  • 1Laboratory of Pathophysiological Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aoba Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan. hirasawa@mail.pharm.tohoku.ac.jp

Insights

Lipopolysaccharide (LPS) increases histamine decarboxylase (HDC) mRNA in RAW 264 cells. The transcription factor Sp1 plays a key role in this LPS-induced HDC expression, as shown by inhibitor studies and binding assays.

Area of Science:

  • Immunology and Molecular Biology
  • Gene Regulation and Transcription Factor Function

Background:

  • Lipopolysaccharide (LPS) is a potent immune activator.
  • Histamine decarboxylase (HDC) is involved in histamine synthesis.
  • Understanding gene regulation during immune responses is crucial.

Purpose of the Study:

  • To investigate the role of the transcription factor Sp1 in LPS-induced HDC gene expression.
  • To analyze the mechanism of HDC mRNA and protein regulation by LPS in RAW 264 cells.

Main Methods:

  • RAW 264 macrophage cell line stimulation with LPS.
  • Quantitative analysis of HDC mRNA levels.
  • Inhibition studies using Mithramycin A (Sp1 inhibitor).
  • Electrophoretic mobility shift assays (EMSA) to assess Sp1-DNA binding.

Main Results:

  • LPS significantly increased HDC mRNA levels in a dose-dependent manner.
  • Mithramycin A reduced LPS-induced HDC mRNA and protein expression.
  • EMSA confirmed Sp1 binding to the HDC gene promoter's GC box.
  • LPS stimulation enhanced Sp1 binding to the GC box without altering Sp1 protein levels.

Conclusions:

  • Sp1 is a critical transcription factor regulating LPS-induced HDC expression in RAW 264 cells.
  • The study elucidates a specific molecular mechanism in LPS-mediated immune cell activation.